CVS Group Plc (CVSG) - Net Assets

Latest as of June 2025: GBX301.70 Million GBX ≈ $36.71K USD

Based on the latest financial reports, CVS Group Plc (CVSG) has net assets worth GBX301.70 Million GBX (≈ $36.71K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX696.20 Million ≈ $84.71K USD) and total liabilities (GBX394.50 Million ≈ $48.00K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check CVS Group Plc tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	GBX301.70 Million
% of Total Assets	43.34%
Annual Growth Rate	N/A
5-Year Change	57.88%
10-Year Change	547.42%
Growth Volatility	582.72

CVS Group Plc - Net Assets Trend (2005–2025)

This chart illustrates how CVS Group Plc's net assets have evolved over time, based on quarterly financial data. See CVS Group Plc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for CVS Group Plc (2005–2025)

The table below shows the annual net assets of CVS Group Plc from 2005 to 2025. For live valuation and market cap data, see market value of CVS Group Plc.

Year	Net Assets	Change
2025-06-30	GBX301.70 Million ≈ $36.71K	+15.82%
2024-06-30	GBX260.50 Million ≈ $31.70K	+1.36%
2023-06-30	GBX257.00 Million ≈ $31.27K	+18.22%
2022-06-30	GBX217.40 Million ≈ $26.45K	+13.76%
2021-06-30	GBX191.10 Million ≈ $23.25K	+14.71%
2020-06-30	GBX166.60 Million ≈ $20.27K	+2.15%
2019-06-30	GBX163.10 Million ≈ $19.84K	+3.42%
2018-06-30	GBX157.70 Million ≈ $19.19K	+79.20%
2017-06-30	GBX88.00 Million ≈ $10.71K	+88.84%
2016-06-30	GBX46.60 Million ≈ $5.67K	+19.18%
2015-06-30	GBX39.10 Million ≈ $4.76K	+25.32%
2014-06-30	GBX31.20 Million ≈ $3.80K	+26.32%
2013-06-30	GBX24.70 Million ≈ $3.01K	+21.36%
2012-06-30	GBX20.35 Million ≈ $2.48K	+22.82%
2011-06-30	GBX16.57 Million ≈ $2.02K	+37.53%
2010-06-30	GBX12.05 Million ≈ $1.47K	+2431.30%
2009-06-30	GBX476.00K ≈ $57.92	+139.83%
2008-06-30	GBX-1.20 Million ≈ $-145.40	+22.60%
2007-06-30	GBX-1.54 Million ≈ $-187.86	-51.97%
2006-06-30	GBX-1.02 Million ≈ $-123.62	+15.33%
2005-06-30	GBX-1.20 Million ≈ $-146.01	--

Equity Component Analysis

This analysis shows how different components contribute to CVS Group Plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 20090700000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (June 2025)

Component	Amount	Percentage
Retained Earnings	GBX198.30 Million	66.14%
Common Stock	GBX100.00K	0.03%
Other Comprehensive Income	GBX-7.70 Million	-2.57%
Other Components	GBX109.10 Million	36.39%
Total Equity	GBX299.80 Million	100.00%

CVS Group Plc Competitors by Market Cap

The table below lists competitors of CVS Group Plc ranked by their market capitalization.

Company	Market Cap
RENALYTIX PLC LS-0025 F:2O9	$10.22 Million
GULLBERG+JANSSON AB F:9D7	$10.22 Million
Malaysian Genomics Resource KLSE:0155	$10.23 Million
INCOME ASSET MNG.GRP.LTD. F:C1R	$10.24 Million
Lease IT Public Company Limited BK:LIT	$10.22 Million
Atlas Menkul Kiymetler Yatirim Ortakligi AS IS:ATLAS	$10.21 Million
Emerge Commerce Ltd V:ECOM	$10.21 Million
Rigsave S.P.A. XETRA:H68	$10.21 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in CVS Group Plc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 260,400,000 to 299,800,000, a change of 39,400,000 (15.1%).
Net income of 19,300,000 contributed positively to equity growth.
Dividend payments of 5,700,000 reduced retained earnings.
Other comprehensive income decreased equity by 9,199,999.
Other factors increased equity by 34,999,999.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	GBX19.30 Million	+6.44%
Dividends Paid	GBX5.70 Million	-1.9%
Other Comprehensive Income	GBX-9.20 Million	-3.07%
Other Changes	GBX35.00 Million	+11.67%
Total Change	GBX-	15.13%

Book Value vs Market Value Analysis

This analysis compares CVS Group Plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 286.47x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2005-06-30	GBX-0.02	GBX1197.00	x
2006-06-30	GBX-0.02	GBX1197.00	x
2007-06-30	GBX-0.03	GBX1197.00	x
2008-06-30	GBX-0.02	GBX1197.00	x
2009-06-30	GBX0.01	GBX1197.00	x
2010-06-30	GBX0.22	GBX1197.00	x
2011-06-30	GBX0.29	GBX1197.00	x
2012-06-30	GBX0.35	GBX1197.00	x
2013-06-30	GBX0.42	GBX1197.00	x
2014-06-30	GBX0.52	GBX1197.00	x
2015-06-30	GBX0.65	GBX1197.00	x
2016-06-30	GBX0.76	GBX1197.00	x
2017-06-30	GBX1.40	GBX1197.00	x
2018-06-30	GBX2.36	GBX1197.00	x
2019-06-30	GBX2.31	GBX1197.00	x
2020-06-30	GBX2.35	GBX1197.00	x
2021-06-30	GBX2.69	GBX1197.00	x
2022-06-30	GBX3.04	GBX1197.00	x
2023-06-30	GBX3.59	GBX1197.00	x
2024-06-30	GBX3.63	GBX1197.00	x
2025-06-30	GBX4.18	GBX1197.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently CVS Group Plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 6.44%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 2.87%
• Asset Turnover: 0.97x
• Equity Multiplier: 2.32x
Recent ROE (6.44%) is below the historical average (39.91%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2005	0.00%	2.94%	1.08x	0.00x	GBX498.00K
2006	0.00%	0.67%	1.01x	0.00x	GBX237.60K
2007	0.00%	0.89%	1.02x	0.00x	GBX500.40K
2008	0.00%	-0.55%	1.18x	0.00x	GBX-219.50K
2009	638.24%	3.97%	1.28x	126.20x	GBX2.99 Million
2010	25.38%	3.58%	1.12x	6.31x	GBX1.85 Million
2011	21.04%	3.44%	1.31x	4.68x	GBX1.83 Million
2012	14.19%	2.66%	1.36x	3.92x	GBX852.70K
2013	16.19%	3.33%	1.38x	3.53x	GBX1.53 Million
2014	15.38%	3.36%	1.50x	3.05x	GBX1.68 Million
2015	17.39%	4.06%	1.32x	3.25x	GBX2.89 Million
2016	15.02%	3.21%	1.06x	4.43x	GBX2.34 Million
2017	13.07%	4.23%	1.03x	2.99x	GBX2.70 Million
2018	6.79%	3.27%	1.03x	2.02x	GBX-5.07 Million
2019	5.03%	2.02%	1.08x	2.31x	GBX-8.11 Million
2020	3.42%	1.33%	0.92x	2.79x	GBX-10.96 Million
2021	10.10%	3.78%	1.05x	2.54x	GBX190.00K
2022	11.82%	4.64%	1.07x	2.38x	GBX3.96 Million
2023	16.30%	7.11%	1.03x	2.23x	GBX16.20 Million
2024	2.38%	0.96%	0.94x	2.65x	GBX-19.84 Million
2025	6.44%	2.87%	0.97x	2.32x	GBX-10.68 Million

Industry Comparison

This section compares CVS Group Plc's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

Industry: Medical Care Facilities
Average net assets among peers: $314,340,000
Average return on equity (ROE) among peers: -50.52%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
CVS Group Plc (CVSG)	GBX301.70 Million	0.00%	1.31x	$10.22 Million
Kanabo Group PLC (KNB)	$674.00K	-53.56%	0.05x	$16.93K
Spire Healthcare Group Plc (SPI)	$939.90 Million	0.77%	1.43x	$10.55 Million
Totally PLC (TLY)	$2.45 Million	-98.77%	0.28x	$5.74K

About CVS Group Plc

LSE:CVSG UK Medical Care Facilities

Market Cap

$10.22 Million

GBX83.98 Billion GBX

Market Cap Rank

#26999 Global

#351 in UK

Share Price

GBX1197.00

Change (1 day)

-1.48%

52-Week Range

GBX1114.00 - GBX1424.00

All Time High

GBX2715.77